US Patent 7405234 Bicyclic modulators of androgen receptor function
Patent 7405234 was granted and assigned to Bristol-Myers Squibb on July, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 14 Sep, 2023
Golden AI
Edits made to:
Article (+70 characters)
Article
Patent abstract
The invention provides compounds according to formula I
Edits on 26 Jul, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07405234 Bicyclic modulators of androgen receptor function US Patent 7405234 Bicyclic modulators of androgen receptor function
Infobox
Patent Number
0740523400
Patent Number
740523400
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074052340
Date of Patent
July 29, 2008
0Patent Application Number
107804150
Date Filed
February 17, 2004
0Official Website
Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
074052340
Date of Patent
July 29, 2008
0Patent Application Number
107804150
Date Filed
February 17, 2004
0Official Website
Patent Primary Examiner
Edits on 9 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07405234 Bicyclic modulators of androgen receptor function
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07405234
Date of patent
July 29, 2008
Patent application number
10780415
Date Filed
February 17, 2004
Patent primary examiner
Find more entities like US Patent 7405234 Bicyclic modulators of androgen receptor function
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
